Skip to main content

Swiss National Bank

Bank

Position in DNLI — Denali Therapeutics Inc.

CIK 1582202 ZURICH, V8

Position in DNLI

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,957,260
+$1,700,300 QoQ
Shares Held
270,500
-1.2% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. DNLI ranks #43 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,957,260 270,500
2026-03-31 $5,256,960 273,800
2025-12-31 $4,520,438 273,800
2025-09-30 $3,884,100 267,500
2025-06-30 $3,510,091 250,900
2025-03-31 $3,410,985 250,900
2024-12-31 $5,166,330 253,500
2024-09-30 $7,302,891 250,700
2024-06-30 $5,405,616 232,800
2024-03-31 $4,477,464 218,200
2023-12-31 $4,650,382 216,700
2023-09-30 $4,967,704 240,800
2023-06-30 $7,026,331 238,100
2023-03-31 $4,727,808 205,200
2022-12-31 $5,798,385 208,500
2022-09-30 $6,263,829 204,100
2022-06-30 $5,927,202 201,400
2022-03-31 $6,038,309 187,700
2021-12-31 $7,747,020 173,700
2021-09-30 $8,783,345 174,100
2021-06-30 $13,475,992 171,800
2021-03-31 $10,169,510 178,100
2020-12-31 $14,641,248 174,800
2020-09-30 $6,435,068 179,600
2020-06-30 $4,267,770 176,500
2020-03-31 $2,120,461 121,100